NCNA
NuCana Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.98
−1.30%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-48.3%
Return on equity
-38.0%
Return on assets
-63.9%
Return on invested capital
0.00x
Asset turnover
-$6.6M
Cash from operations
$6.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026